2025-03-29 20:34:40
Latest Post
Bharat's largest solar cell manufacturing Gigafactory inaugurated by Waaree Energies in Chikhli, Gujarat
Purple Finance Limited sells portion of its portfolio to Ambit Finvest Pvt Ltd
Kumbhat Financial Services Limited allots 5.78 lakh shares to promoter Sanjay Kumbhat 
Solarium Green Energy Ltd receives order from BSF Jammu
RITES Ltd receives LoA from Oil India Ltd
Stock Report
Chemo Pharma Laboratories Ltd Q3FY22 net profit at Rs. 27.91 lakhs
Posted On : 2022-01-28 19:54:54( TIMEZONE : IST )
CHEMO PHARMA LABORATORIES LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.3613 crores during the period ended December 31, 2021 as compared to Rs. 0.1896 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.2791 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.1119 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.86 for the period ended December 31, 2021 as compared to Rs. 0.75 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 0.3613 crs | ₹0.1896 crs |  90.56% |
| Net Profit | ₹0.2791 crs | ₹0.1119 crs | 149.42% |
| EPS | ₹1.86 | ₹0.75 | 148.00% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.3613 crores during the period ended December 31, 2021 as compared to Rs.0.1116 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.2791 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.0449 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.86 for the period ended December 31, 2021 as compared to Rs.0.30 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 0.3613 crs | ₹0.1116 crs | 223.75% |
| Net Profit | ₹0.2791 crs | ₹0.0449 crs | 521.60% |
| EPS | ₹1.86 | ₹0.30 | 520.00% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.0.6601 crores during the 9 Months period ended December 31, 2021 as compared to Rs.0.4106 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.4221 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.2303 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.2.81 for the 9 Months period ended December 31, 2021 as compared to Rs.1.54 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹0.6601 crs | ₹0.4106 crs | 60.76% |
| Net Profit | ₹0.4221 crs | ₹0.2303 crs | 83.28% |
| EPS | ₹2.81 | ₹1.54 | 82.47% |
Shares of CHEMO PHARMA LABORATORIES LTD. was last trading in BSE at Rs. 44.30 as compared to the previous close of Rs. 42.20. The total number of shares traded during the day was 2266 in over 25 trades.
The stock hit an intraday high of Rs. 44.30 and intraday low of 40.15. The net turnover during the day was Rs. 96760.00.
